07-2980
ジエチレングリコールモノエチルエーテル
SAJ first grade, ≥98.0%
別名:
2-(2-エトキシエトキシ)エタノール, CARBITOL™, エチルジグリコール, ジエチレングリコールエチルエーテル
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
C2H5OCH2CH2OCH2CH2OH
CAS番号:
分子量:
134.17
EC Number:
203-919-7
UNSPSC Code:
12352112
PubChem Substance ID:
Beilstein/REAXYS Number:
1736441
MDL number:
InChI key
XXJWXESWEXIICW-UHFFFAOYSA-N
InChI
1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3
SMILES string
CCOCCOCCO
grade
SAJ first grade
vapor density
4.63 (vs air)
vapor pressure
0.12 mmHg ( 20 °C)
assay
≥98.0%
form
liquid
expl. lim.
1.2 %, 135 °F, 23.5 %, 182 °F
availability
available only in Japan
refractive index
n20/D 1.427 (lit.)
bp
202 °C (lit.)
density
0.999 g/mL at 25 °C (lit.)
類似した製品をお探しですか？ 訪問 製品比較ガイド
Legal Information
CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow
保管分類
10 - Combustible liquids
wgk
WGK 1
flash_point_f
204.8 °F - closed cup
flash_point_c
96 °C - closed cup
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
第4類:引火性液体 + 第三石油類 + 危険等級III + 水溶性液体
fsl
名称等を表示すべき危険物及び有害物
ishl_indicated
名称等を通知すべき危険物及び有害物
ishl_notified
07-2980-5-500ML-J:
jan
Yousef Javadzadeh et al.
Colloids and surfaces. B, Biointerfaces, 82(2), 422-426 (2010-10-19)
Regarding the potential severe toxicity associated with systemic administration of methotrexate (MTX), a topical formulation might be of greater utility for the treatment of psoriasis and other hyperproliferative skin disorders. One of the presumed reasons for the lack of clinical
Liandong Hu et al.
International journal of pharmaceutics, 420(2), 251-255 (2011-09-13)
The objective of the present study was to formulate a microemulsion system for oral administration to improve the solubility and bioavailability of fenofibrate. Various formulations were prepared using different ratios of oils, surfactants and co-surfactants (S&CoS). Pseudo-ternary phase diagrams were
Dong Hoon Oh et al.
International journal of pharmaceutics, 420(2), 412-418 (2011-09-29)
In order to compare the effects of hydrophilic and hydrophobic solid carrier on the formation of solid self-microemulsifying drug delivery system (SMEDDS), two solid SMEDDS formulations were prepared by spray-drying the solutions containing liquid SMEDDS and solid carriers. Colloidal silica
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Roberta Censi et al.
Drug development and industrial pharmacy, 38(9), 1128-1133 (2011-12-23)
A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）